Detalles de la búsqueda
1.
High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
Diabetologia
; 67(2): 392-402, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010533
2.
Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
Diabetologia
; 67(2): 371-391, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38017352
3.
Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
Diabetologia
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38777868
4.
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
Diabetologia
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795153
5.
The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode.
Cardiovasc Diabetol
; 23(1): 55, 2024 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38331900
6.
Associations of clinical, psychological, and sociodemographic characteristics and ecological momentary assessment completion in the 10-week Hypo-METRICS study: Hypoglycaemia MEasurements ThResholds and ImpaCtS.
Diabet Med
; : e15345, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38760977
7.
Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
Diabetes Obes Metab
; 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774963
8.
Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
Diabetologia
; 66(7): 1340-1352, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37015997
9.
Producing a preference-based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed-methods research protocol.
Diabet Med
; 40(3): e15007, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36398992
10.
Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics.
Diabetes Obes Metab
; 25(3): 656-663, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309941
11.
iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study.
Diabetes Obes Metab
; 25(1): 68-77, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36123617
12.
Hypoglycaemia induces a sustained pro-inflammatory response in people with type 1 diabetes and healthy controls.
Diabetes Obes Metab
; 25(11): 3114-3124, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37485887
13.
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
Diabetologia
; 65(10): 1601-1612, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35867127
14.
Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
Diabetologia
; 65(1): 159-172, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618177
15.
Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis.
J Biol Chem
; 296: 100439, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33610549
16.
Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes.
Diabet Med
; 39(12): e14973, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36251572
17.
Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
Diabet Med
; 39(9): e14892, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35633291
18.
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
Diabetes Obes Metab
; 24(12): 2364-2372, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36053820
19.
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.
Diabetes Obes Metab
; 24(12): 2391-2399, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054624
20.
Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 24(7): 1360-1369, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403793